ProShare Advisors LLC Boosts Stake in The Clorox Company $CLX

ProShare Advisors LLC grew its stake in The Clorox Company (NYSE:CLX) by 11.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,297,016 shares of the company’s stock after acquiring an additional 136,135 shares during the quarter. ProShare Advisors LLC owned about 1.07% of Clorox worth $159,922,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in CLX. Total Investment Management Inc. bought a new position in Clorox in the second quarter worth about $25,000. NewSquare Capital LLC boosted its holdings in shares of Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after buying an additional 193 shares in the last quarter. True Wealth Design LLC raised its stake in shares of Clorox by 1,020.0% during the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock worth $28,000 after acquiring an additional 204 shares in the last quarter. Darwin Wealth Management LLC bought a new position in shares of Clorox during the 2nd quarter worth approximately $29,000. Finally, Root Financial Partners LLC acquired a new stake in Clorox in the third quarter valued at approximately $29,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CLX. TD Cowen upped their price target on Clorox from $108.00 to $111.00 and gave the stock a “hold” rating in a research report on Wednesday, February 4th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Royal Bank Of Canada set a $132.00 price target on Clorox in a report on Wednesday. Wells Fargo & Company upped their price objective on shares of Clorox from $108.00 to $115.00 and gave the company an “equal weight” rating in a report on Friday, January 23rd. Finally, UBS Group increased their price objective on shares of Clorox from $115.00 to $121.00 and gave the company a “neutral” rating in a research report on Wednesday. One research analyst has rated the stock with a Buy rating, ten have given a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $117.93.

Insider Activity at Clorox

In related news, Director Pierre R. Breber bought 4,000 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is owned by insiders.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target on CLX to $136 (maintained equal-weight), citing valuation/earnings dynamics — a catalyst supporting the stock’s rally. Clorox (NYSE:CLX) Price Target Raised to $136.00 at Morgan Stanley
• Positive Sentiment: Investor write-ups are bullish: a Seeking Alpha piece frames CLX as a defensive, dividend-rich value after “solid” Q2 results and attractive valuation — supporting buy interest from income-focused investors. Clorox: Solid Q2 Results And Cheap Valuation MakesThis Defensive Dividend Stock A Strong Buy
• Neutral Sentiment: TD Cowen nudged its price target to $111 and kept a Hold rating — a modest recalibration that tempers upside expectations despite the recent positive headlines. TD Cowen Adjusts Clorox Price Target
• Neutral Sentiment: Company reported mixed Q2 results and reaffirmed its 2026 outlook — revenue roughly flat year-over-year and an EPS miss by a few cents; reassurances on the outlook limit downside but leave questions on near-term margin recovery. Clorox Posts Mixed Q2 Results, Reaffirms 2026 Outlook
• Neutral Sentiment: Management is weighing a potential GOJO acquisition and finishing an ERP implementation; strategic moves could boost long-term growth but add execution risk in the near term. Clorox Weighs GOJO Deal And ERP Finish Against Softer Earnings
• Neutral Sentiment: Q2 earnings call transcript is available for deeper read on management commentary around pricing, cost savings and margin plans — useful for gauging execution risk. Clorox (CLX) Q2 2026 Earnings Call Transcript
• Negative Sentiment: Some brokerages have a consensus “Reduce” rating on CLX, which may cap upside as institutional flows react to conservative guidance and margin concerns. The Clorox Company Given Consensus Rating of “Reduce” by Brokerages
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 EPS miss — a reminder that cost and margin recovery, not just revenue, will drive forecast revisions and investor sentiment. BofA Flags Margin Uncertainty for Clorox After Q2 Earnings Miss
• Neutral Sentiment: A Zacks piece highlights using its Earnings ESP tool to find staples stocks that might beat — general market research, not CLX-specific guidance, but could affect short-term trading interest. Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now

Clorox Price Performance

Shares of NYSE CLX opened at $119.52 on Monday. The Clorox Company has a 52 week low of $96.66 and a 52 week high of $159.04. The company has a quick ratio of 0.48, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The firm has a market cap of $14.45 billion, a P/E ratio of 19.53, a P/E/G ratio of 0.59 and a beta of 0.59. The business’s 50 day moving average price is $105.83 and its 200 day moving average price is $113.73.

Clorox (NYSE:CLX) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the company earned $1.55 earnings per share. The firm’s revenue was down .8% on a year-over-year basis. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s payout ratio is 81.05%.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.